A proteomic approach identified growth hormone-dependent nutrition markers in children with idiopathic short stature

Proteome Science

Volumn 6, Issue , 2008, Pages

  Hellgren, Gunnel ^a   Andersson, Björn ^a   Nierop, Andreas F M ^b   Dahlgren, Jovanna ^a   Hochberg, Ze'ev ^a,c   Albertsson Wikland, Kerstin ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Muvara bv   (Netherlands)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; BIOLOGICAL MARKER; GROWTH HORMONE; PREALBUMIN; PROTEIN; RECOMBINANT GROWTH HORMONE;

ANTIBODY SPECIFICITY; ARTICLE; CATION EXCHANGE; CHILD; CHILD NUTRITION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONE SENSITIVITY; HUMAN; MALE; PREPUBERTY; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEOMICS; SHORT STATURE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 58249112864     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-6-35     Document Type: Article

References (35)

1. Rosenfeld RG Pharmacogenomics and pharmacoproteomics in the evaluation and management of short stature European journal of endocrinology/ European Federation of Endocrine Societies 2007, 157(Suppl 1): S27-31 17785693
2. Rosenfeld RG The molecular basis of idiopathic short stature Growth Horm IGF Res 2005, 15(Suppl A):S3-5 10.1016/j.ghir.2005.06.014 16023877
3. Hochberg Z Albertsson-Wikland K Evo-devo of infantile and childhood growth Pediatr Res 2008, 64(1):2-7 18652011
4. Kristrom B Lofqvist C Rosberg S Albertsson Wikland K Effect of spontaneous GH secretion and the GH sampling period on the accuracy of models for predicting growth responses to GH treatment J Clin Endocrinol Metab 2001, 86(10):4963-4964 10.1210/jc.86.10.4963 11600570
5. Ranke MB Lindberg A Chatelain P Wilton P Cutfield W Albertsson-Wikland K Price DA Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study J Clin Endocrinol Metab 1999, 84(4):1174-1183 10.1210/jc.84.4.1174 10199749
6. Wikland KA Kristrom B Rosberg S Svensson B Nierop AF Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities Pediatr Res 2000, 48(4):475-484 10.1203/00006450-200010000-00010 11004238
7. Dahlgren J Kristrom B Niklasson A Nierop AF Rosberg S Albertsson-Wikland K Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age BMC Med Inform Decis Mak 2007, 7(1):40 2246105 18076760 10.1186/ 1472-6947-7-40
8. Albertsson-Wikland K Luo ZC Niklasson A Karlberg J Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference Acta Paediatr 2002, 91(7):739-754 10.1080/08035250213216 12200898
9. Löfqvist C Andersson E Gelander L Rosberg S Blum WF Albertsson-Wikland K Reference values for IGF-I throughout childhood and adolescence: A model that accounts simultaneously for the effect of gender, age, and puberty J Clin Endocrinol Metab 2001, 86(12):5870-5876 10.1210/jc.86.12.5870 11739455
10. Shevchenko A Tomas H Havlis J Olsen JV Mann M In-gel digestion for mass spectrometric characterization of proteins and proteomes Nature protocols 2006, 1(6):2856-2860 10.1038/nprot.2006.468 17406544
11. Kozak KR Su F Whitelegge JP Faull K Reddy S Farias-Eisner R Characterization of serum biomarkers for detection of early stage ovarian cancer Proteomics 2005, 5(17):4589-4596 10.1002/pmic.200500093 16237736
12. Escher N Kaatz M Melle C Hipler C Ziemer M Driesch D Wollina U von Eggeling F Posttranslational modifications of transthyretin are serum markers in patients with mycosis fungoides Neoplasia 2007, 9(3):254-259 1838582 17401465
13. Thissen JP Underwood LE Ketelslegers JM Regulation of insulin-like growth factor-I in starvation and injury Nutrition reviews 1999, 57(6):167-176 10439629
14. Kristrom B Carlsson B Rosberg S Carlsson LM Albertsson-Wikland K Short-term changes in serum leptin levels provide a strong metabolic marker for the growth response to growth hormone treatment in children. Swedish Study Group for Growth Hormone Treatment J Clin Endocrinol Metab 1998, 83(8):2735-2741 10.1210/jc.83.8.2735 9709940
15. Connolly CM Barrow RE Chinkes DL Martinez JA Herndon DN Recombinant human growth hormone increases thyroid hormone-binding sites in recovering severely burned children Shock (Augusta, Ga) 2003, 19(5):399-403 10.1097/01.shk.0000051758.08171.bc 12744480
16. Luo SM Liang LJ Lai JM Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis World J Gastroenterol 2004, 10(9):1292-1296 15112344
17. Vranckx R Rouaze-Romet M Savu L Mechighel P Maya M Nunez EA Regulation of rat thyroxine-binding globulin and transthyretin: Studies in thyroidectomized and hypophysectomized rats given tri-iodothyronine or/ and growth hormone The Journal of endocrinology 1994, 142(1):77-84 10.1677/joe.0.1420077 7964287
18. Refai E Dekki N Yang SN Imreh G Cabrera O Yu L Yang G Norgren S Rossner SM Inverardi L et al Transthyretin constitutes a functional component in pancreatic beta-cell stimulus-secretion coupling Proc Natl Acad Sci USA 2005 102 47 17020 17025 1287967 16286652 10.1073/pnas.0503219102
19. Hochberg Z Hertz P Maor G Oiknine J Aviram M Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein Endocrinology 1992, 131(1):430-435 10.1210/ en.131.1.430 1612024
20. Kuromaru R Kohno H Ueyama N Hassan HM Honda S Hara T Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects J Clin Endocrinol Metab 1998, 83(11):3890-3896 10.1210/jc.83.11.3890 9814464
21. Castellani LW Goto AM Lusis AJ Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance Diabetes 2001, 50(3):643-651 10.2337/diabetes.50.3.643 11246886
22. Elbein SC Hoffman MD Teng K Leppert MF Hasstedt SJ A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians Diabetes 1999, 48(5):1175-1182 10.2337/diabetes.48.5.1175 10331426
23. Hanson RL Ehm MG Pettitt DJ Prochazka M Thompson DB Timberlake D Foroud T Kobes S Baier L Burns DK et al An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians American journal of human genetics 1998, 63(4):1130-1138 1377493 9758619 10.1086/302061
24. Vionnet N Hani EH Dupont S Gallina S Francke S Dotte S De Matos F Durand E Lepretre F Lecoeur C et al Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24 American journal of human genetics 2000, 67(6):1470-1480 1287924 11067779 10.1086/316887
25. de Ridder MA Stijnen T Hokken-Koelega AC Prediction of adult height in growth-hormone-treated children with growth hormone deficiency J Clin Endocrinol Metab 2007, 92(3):925-931 10.1210/jc.2006-1259 17179199
26. Reiter EO Price DA Wilton P Albertsson-Wikland K Ranke MB Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: Analysis of a large international database J Clin Endocrinol Metab 2006, 91(6):2047-2054 10.1210/ jc.2005-2284 16537676
27. Albertsson-Wikland K Hall K Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels J Clin Endocrinol Metab 1987, 65(4):671-678 3654912
28. Baggerly KA Morris JS Edmonson SR Coombes KR Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer Journal of the National Cancer Institute 2005, 97(4):307-309 15713966
29. Diamandis EP Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: Opportunities and potential limitations Mol Cell Proteomics 2004, 3(4):367-378 10.1074/mcp.R400007-MCP200 14990683
30. Diamandis EP Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: Next steps Cancer Res 2006, 66(11):5540-5541 10.1158/ 0008-5472.CAN-05-4503 16740686
31. Coombes KR Morris JS Hu J Edmonson SR Baggerly KA Serum proteomics profiling - a young technology begins to mature Nature biotechnology 2005, 23(3):291-292 10.1038/nbt0305-291 15765078
32. Karsan A Eigl BJ Flibotte S Gelmon K Switzer P Hassell P Harrison D Law J Hayes M Stillwell M et al Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis Clinical chemistry 2005, 51(8):1525-1528 10.1373/clinchem.2005.050708 15951319
33. Timms JF Arslan-Low E Gentry-Maharaj A Luo Z T'Jampens D Podust VN Ford J Fung ET Gammerman A Jacobs I et al Preanalytic influence of sample handling on SELDI-TOF serum protein profiles Clinical chemistry 2007, 53(4):645-656 10.1373/clinchem.2006.080101 17303688
34. Rollin D Whistler T Vernon SD Laboratory methods to improve SELDI peak detection and quantitation Proteome science 2007, 5:9 1934350 17605798 10.1186/1477-5956-5-9
35. Chung L Clifford D Buckley M Baxter RC Novel biomarkers of human growth hormone action from serum proteomic profiling using protein chip mass spectrometry J Clin Endocrinol Metab 2006, 91(2):671-677 10.1210/ jc.2005-1137 16303837